Blog

 

Blog

MHRA confirms UK stance in Brexit update to pharma industry

18 January 2018

By Helen Kimberley and Julia Fraser

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published an update to pharmaceutical companies in the UK on the status of the Brexit negotiations and confirmed the UK's wish for there to be a transition period to allow for a smooth withdrawal. The update, published on 16 January 2018, also sets out the MHRA's expectations for continued involvement in EU affairs during the negotiation period, while the UK remains part of the EU, and clarifies the MHRA's intended approach should a transition or implementation period not be concluded with the EU by March 2019.

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom

Blog

How will Brexit impact UK and EU influence over international economic regulation?

15 January 2018

By Rachel Brandenburger* and Andrew Eaton

With the EU and the UK having made "sufficient progress" on the terms of the UK's withdrawal from the EU during phase one of the Brexit negotiations, attention has shifted to the framework for the future relationship between the UK and the EU post-Brexit and the necessary transitional arrangements.  These issues will no doubt come to dominate discussions about Brexit in the coming months.  However, a wider and equally important consequence of Brexit also needs consideration: the effect of Brexit on the UK's and the EU's respective relationships with the rest of the world through the exercise of "soft power".

Read more

Jurisdictions: United Kingdom

Blog

Brexit negotiations poised for intense start to 2018

21 December 2017

By Charles Brasted and Andrew Eaton

In what looks set to be the last major Brexit development of 2017, the European Commission yesterday published its recommended draft negotiating directives for the next phase of the Article 50 negotiations.  The Council will decide whether to adopt the directives in January 2018, which would formally allow the EU to begin negotiating the second phase of the talks.

Read more

Jurisdictions: United Kingdom

Blog

Brexit Bill – Impact on patents

22 November 2017

By Katie McConnell

*Reposted from www.limegreenipnews.com - Link

The UK government’s draft EU Withdrawal Bill (the “Brexit Bill“) aims to incorporate EU directives and regulations into UK domestic law in their current form immediately following Brexit (“Retained EU Law“).  This article considers the impact the Brexit Bill will have on some key patent issues

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom

Blog

UK publishes paper on Brexit and medicines regulation

21 November 2017

By Jane Summerfield

On the same day as the European Council voted to move the European Medicines Agency (EMA) from London to Amsterdam, the UK Parliament issued a briefing paper on Brexit and medicines regulation. 

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: United Kingdom